New eye injection shows promise for restoring sight after stroke in the eye
NCT ID NCT06178055
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called KUS121, given as an eye injection, for people who suddenly lost vision due to a blocked artery in the eye (central retinal artery occlusion). The goal was to see if the injection could improve vision better than a sham procedure. The trial included 17 adults who received the treatment within 48 hours of vision loss.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL RETINAL ARTERY OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Austin Retina Associates
Austin, Texas, 78705, United States
-
Cumberland Valley Retina Consultants
Hagerstown, Maryland, 21740, United States
-
Florida Retina Institute
Jacksonville, Florida, 32216, United States
-
Kaiser Permanente Oakland Med Ctr.
Oakland, California, 94611, United States
-
Kresge Eye Institute/Wayne State University
Detroit, Michigan, 48201, United States
-
NYEE Infirmary of Mount Sinai
New York, New York, 10003, United States
-
Retina Consultants of Texas
San Antonio, Texas, 78240, United States
-
Retina Consultants of Texas
The Woodlands, Texas, 77384, United States
-
Salehi Retina Institute, Inc
Huntington Beach, California, 92647, United States
-
The Retina Partners
Encino, California, 91436, United States
-
UH Eye Institute
Cleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.